Herediter Anjioödemli Çocuk Hastalarda Alerjik Hastalık Birlikteliğinin Araştırılması

Yıl 2023, Cilt: 45 Sayı: 3, 321 - 325, 23.05.2023

Ayşe Aydoğdu , Ali Aydoğdu

https://doi.org/10.20515/otd.1186392

Öz

Herediter anjiyoödem(HAE); C1 esteraz inhibitörün (C1-İNH) eksikliği veya disfonksiyonundan kaynaklanan; nadir görülen otosomal dominant bir hastalıktır. Herediter anjioödemle birlikte görülebilen hastalıklarla ilgili çalışmalarda alerjik hastalıkların sağlıklı popülasyona göre arttığı görülmüş, ancak şimdiye kadar bu konu ile ilgili bir çalışma yapılmamıştır. Bu çalışma herediter anjioödemli hastalarda atopik duyarlılık ve alerjik hastalıkların eşlik etme sıklığını belirlemek amacı ile yapıldı. Bu çalışmada 2019-2021 tarihleri arasında Mersin Şehir Hastanesi çocuk alerji polikliniğinde herediter anjioödem tanısı olan 32 hasta incelenmiştir. Bu gruptaki hastalarda atopik hastalıkların varlığı dosyalarından alınarak kaydedildi. Hastaların 6 (% 18,8)’sında astım, 18 (% 46,9)’inde rinit, 2 (% 6,2)’sinde ürtiker varlığı saptanırken, dermatit varlığına hastaların hiçbirinde rastlanılmadı. Fx5 testi hastalardan 5 (% 15,6)’inde pozitif iken, inhalan alerjen mix sps İgE 7 (% 25,9) hastada pozitif saptandı. IGE değerinin 12 (% 52,2) hastada 100 üstünde olduğu, eozinofil düzeyinin 16 (%50) hastada %4’ün üstünde olduğu gözlendi. Sonuç olarak bu çalışma ile herediter anjioödemli hastalarda atopik hastalık ve atopik duyarlılık birlikteliğinin sağlıklı popülasyona göre daha sık gözlendiğini düşünmekteyiz. Ancak doğrulamak için daha geniş hasta grubu ile çalışmaya ihtiyaç vardır.

Anahtar Kelimeler

Hereditary angioedema, allergic inflammation, bradykinin, Allergy, Bradykinin

Analysis of the Association of Allergic Disease in Pediatric Patients with Hereditary Angioedema

Öz

Hereditary angioedema (HAE) is a rare autosomal dominant disease that is derived from the deficiency or dysfunction of C1 esterase inhibitor (C1-INH). In studies about the diseases that can accompany hereditary angioedema, allergic diseases occur more frequently compared to the healthy population but no studies on this issue have been carried out. This study was conducted in order to determine the frequency of the comorbidity of atopic sensitivity and allergic diseases in patients with hereditary angioedema. 32 patients who were diagnosed with hereditary angioedema in the Paediatric Allergy Polyclinic of Mersin City Hospital between 2019 and 2021 were included in the study. In these patients, the information about the existence of atopic diseases was obtained from their files and recorded. While asthma was observed in 6 (18.8%), allergic rhinitis in 18 (46.9%), and urticaria in 2 (6.2%) patients, dermatitis was not observed in any of the patients. While Fx5 test was positive in 5 (15.6%) patients, inhalant allergen mix sps IgE was positive in 7 (25.9%) patients. The IgE value was above 100 in 12 (52.2%) patients, and the eosinophil level was above 4% in 16 (50%) patients. In conclusion, we speculate in this study that the association of atopic disease and atopic sensitivity is observed more frequently in patients with angioedema than in the healthy population. However, a study with a larger sample is necessary to confirm this finding. 

Anahtar Kelimeler

Allergy, Bradykinin, Hereditary angioedema,

Kaynakça

• 1. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001 Nov 12;161(20):2417-29. PubMed PMID: 11700154. Epub 2001/12/01.
• 2. Bowen T, Cicardi M, Bork K, et al. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol. 2008 Jan;100(1 Suppl 2):S30-40. PubMed PMID: 18220150. Epub 2008/01/29.
• 3. Burks AW, Holgate ST, O'Hehir RE,et al. Middleton's Allergy Principles and Practice 9ed. Amsterdam: Elsevier; 2020.
• 4. Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med. 1976 May;84(5):580-93. PubMed PMID: 1275365. Epub 1976/05/01.
• 5. Farkas H, Martinez-Saguer I, Bork K, et al. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Allergy. 2017 Feb;72(2):300-13. PubMed PMID: 27503784. Pubmed Central PMCID: PMC5248622. Epub 2016/08/10.
• 6. Nanda MK, Elenburg S, Bernstein JA, et al. Clinical features of pediatric hereditary angioedema. J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):392-5. PubMed PMID: 25609346. Pubmed Central PMCID: PMC8207479. Epub 2015/01/23.
• 7. Busse PJ, Christiansen SC, Riedl MA, et al. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. J Allergy Clin Immunol Pract. 2021 Jan;9(1):132-50 e3. PubMed PMID: 32898710. Epub 2020/09/09.
• 8. Maurer M, Magerl M, Betschel S, et al. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update. Allergy. 2022 Jul;77(7):1961-90. PubMed PMID: 35006617. Epub 2022/01/11.
• 9. Global strategy for asthma management and prevention 2018. Available from: http:// www. ginasthma.org/ local/uploads/files/GINA_Report_2018.
• 10. Scadding GK, Kariyawasam HH, Scadding G, et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007). Clin Exp Allergy. 2017 Jul;47(7):856-89. PubMed PMID: 30239057. Epub 2017/07/01.
• 11. Lio PA, Lee M, LeBovidge J, et al. Clinical management of atopic dermatitis: practical highlights and updates from the atopic dermatitis practice parameter 2012. J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):361-9; quiz 70. PubMed PMID: 25017522. Epub 2014/07/16.
• 12. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018 Jul;73(7):1393-414. PubMed PMID: 29336054. Epub 2018/01/18.
• 13. Sundler Bjorkman L, Persson B, Aronsson D, et al. Comorbidities in hereditary angioedema-A population-based cohort study. Clin Transl Allergy. 2022 Mar;12(3):e12135. PubMed PMID: 35344299. Pubmed Central PMCID: PMC8967273. Epub 2022/03/29.
• 14. To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012 Mar 19;12:204. PubMed PMID: 22429515. Pubmed Central PMCID: PMC3353191. Epub 2012/03/21.
• 15. Kurt E, Metintas S, Basyigit I, et al. Prevalence and risk factors of allergies in Turkey: Results of a multicentric cross-sectional study in children. Pediatr Allergy Immunol. 2007 Nov;18(7):566-74. PubMed PMID: 18001428. Epub 2007/11/16.
• 16. Caccia S, Suffritti C, Cicardi M. Pathophysiology of Hereditary Angioedema. Pediatr Allergy Immunol Pulmonol. 2014 Dec 1;27(4):159-63. PubMed PMID: 25538858. Pubmed Central PMCID: PMC4268578. Epub 2014/12/30.
• 17. Maurer M, Bader M, Bas M, et al. New topics in bradykinin research. Allergy. 2011 Nov;66(11):1397-406. PubMed PMID: 21859431. Epub 2011/08/24.
• 18. Bryant JW, Shariat-Madar Z. Human plasma kallikrein-kinin system: physiological and biochemical parameters. Cardiovasc Hematol Agents Med Chem. 2009 Jul;7(3):234-50. PubMed PMID: 19689262. Pubmed Central PMCID: PMC4905712. Epub 2009/08/20.
• 19. Christiansen SC, Eddleston J, Woessner KM, et al. Up-regulation of functional kinin B1 receptors in allergic airway inflammation. J Immunol. 2002 Aug 15;169(4):2054-60. PubMed PMID: 12165532. Epub 2002/08/08.
• 20. Shirasaki H, Kanaizumi E, Himi T. Immunohistochemical localization of the bradykinin B1 and B2 receptors in human nasal mucosa. Mediators Inflamm. 2009;2009:102406. PubMed PMID: 19404481. Pubmed Central PMCID: PMC2673475. Epub 2009/05/01.